Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis
Condition(s):Age-Related MaculopathyLast Updated:November 7, 2007Suspended
Hide Studies Not Open or Pending
Condition(s):Age-Related MaculopathyLast Updated:November 7, 2007Suspended
Condition(s):Retinitis PigmentosaLast Updated:March 8, 2023Completed
Condition(s):Age-related Macular DegenerationLast Updated:April 26, 2018Completed
Condition(s):Usher Syndrome, Type 2A; Retinitis Pigmentosa; USH2ALast Updated:April 29, 2022Active, not recruiting
Condition(s):Parkinson DiseaseLast Updated:December 16, 2022Completed
Condition(s):Retinitis Pigmentosa; Stargardt Disease 1; Best Disease; Pattern Dystrophy of Macula; ChoroideremiaLast Updated:March 15, 2022Recruiting
Condition(s):Macular Degeneration; Retinal Degeneration; Retinal Diseases; Eye DiseasesLast Updated:March 9, 2023Recruiting
Condition(s):Neovascular (Wet) AMDLast Updated:February 22, 2024Active, not recruiting
Condition(s):Neovascular Age-related Macular Degeneration; Retinal Disease; Retinal Degeneration; Macular DegenerationLast Updated:October 31, 2022Terminated
Condition(s):Multiple Sclerosis; Tomography, Optical Coherence; Retinal Degeneration; Visual AcuityLast Updated:December 12, 2023Enrolling by invitation
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.